| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Cord Diseases | 1 | 2021 | 293 | 0.610 |
Why?
|
| Susac Syndrome | 2 | 2013 | 22 | 0.560 |
Why?
|
| Anorexia Nervosa | 5 | 2011 | 1361 | 0.550 |
Why?
|
| Cauda Equina | 2 | 2013 | 45 | 0.550 |
Why?
|
| Genomic Instability | 2 | 2011 | 704 | 0.540 |
Why?
|
| Gene Dosage | 4 | 2010 | 1218 | 0.470 |
Why?
|
| Polyradiculopathy | 1 | 2013 | 23 | 0.450 |
Why?
|
| Immunocompromised Host | 1 | 2018 | 857 | 0.430 |
Why?
|
| Pregnancy Complications | 2 | 2019 | 2942 | 0.390 |
Why?
|
| Genome-Wide Association Study | 10 | 2014 | 12628 | 0.370 |
Why?
|
| Neurospora crassa | 1 | 2010 | 27 | 0.370 |
Why?
|
| Brain Diseases | 2 | 2018 | 1540 | 0.340 |
Why?
|
| Biomass | 1 | 2010 | 134 | 0.340 |
Why?
|
| Chromium | 1 | 2010 | 132 | 0.340 |
Why?
|
| Organic Chemicals | 1 | 2010 | 211 | 0.330 |
Why?
|
| Case-Control Studies | 17 | 2014 | 22052 | 0.320 |
Why?
|
| Bulimia Nervosa | 1 | 2011 | 206 | 0.320 |
Why?
|
| Magnetic Resonance Imaging | 29 | 2021 | 36286 | 0.310 |
Why?
|
| Phobic Disorders | 4 | 2011 | 437 | 0.310 |
Why?
|
| Carbon | 1 | 2010 | 669 | 0.280 |
Why?
|
| Environment | 2 | 2010 | 1118 | 0.270 |
Why?
|
| Colorectal Neoplasms | 11 | 2014 | 6853 | 0.260 |
Why?
|
| Adenoma | 6 | 2016 | 2148 | 0.260 |
Why?
|
| Nucleic Acid Hybridization | 3 | 2008 | 1304 | 0.250 |
Why?
|
| Survival Analysis | 4 | 2009 | 10185 | 0.240 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 3527 | 0.240 |
Why?
|
| Atrial Premature Complexes | 1 | 2004 | 17 | 0.230 |
Why?
|
| Proportional Hazards Models | 5 | 2009 | 12531 | 0.230 |
Why?
|
| Internal-External Control | 2 | 2005 | 359 | 0.220 |
Why?
|
| Cardiac Tamponade | 1 | 2005 | 174 | 0.220 |
Why?
|
| Psychometrics | 2 | 2011 | 3051 | 0.220 |
Why?
|
| Vena Cava, Superior | 1 | 2004 | 197 | 0.210 |
Why?
|
| Catheter Ablation | 3 | 2005 | 2758 | 0.210 |
Why?
|
| Breast Neoplasms | 14 | 2023 | 21029 | 0.210 |
Why?
|
| Algorithms | 4 | 2011 | 13982 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 15 | 2014 | 15790 | 0.210 |
Why?
|
| Testicular Neoplasms | 1 | 2008 | 801 | 0.200 |
Why?
|
| Models, Genetic | 2 | 2011 | 3442 | 0.200 |
Why?
|
| Radiology, Interventional | 4 | 1998 | 475 | 0.200 |
Why?
|
| Linkage Disequilibrium | 2 | 2010 | 1996 | 0.200 |
Why?
|
| Biometry | 4 | 2010 | 559 | 0.200 |
Why?
|
| Statistics as Topic | 3 | 2005 | 2362 | 0.200 |
Why?
|
| Atrial Fibrillation | 3 | 2005 | 5209 | 0.190 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 2829 | 0.190 |
Why?
|
| Nervous System Diseases | 1 | 2011 | 1647 | 0.190 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2014 | 17790 | 0.180 |
Why?
|
| Dyslexia | 1 | 2002 | 210 | 0.180 |
Why?
|
| Neoplasm Proteins | 2 | 2011 | 3612 | 0.180 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2006 | 3774 | 0.180 |
Why?
|
| Cross-Cultural Comparison | 5 | 2011 | 633 | 0.180 |
Why?
|
| Heart Arrest | 2 | 2020 | 1506 | 0.170 |
Why?
|
| Myoclonus | 1 | 2020 | 107 | 0.170 |
Why?
|
| Catheterization | 1 | 2005 | 1432 | 0.170 |
Why?
|
| Family | 4 | 2010 | 3189 | 0.160 |
Why?
|
| Pulmonary Veins | 1 | 2005 | 745 | 0.160 |
Why?
|
| Data Interpretation, Statistical | 2 | 2007 | 2696 | 0.160 |
Why?
|
| Genome | 4 | 2010 | 1739 | 0.150 |
Why?
|
| Humans | 99 | 2023 | 760613 | 0.150 |
Why?
|
| Hong Kong | 4 | 2005 | 162 | 0.150 |
Why?
|
| Multivariate Analysis | 3 | 2011 | 12159 | 0.150 |
Why?
|
| Colonic Neoplasms | 4 | 2010 | 2526 | 0.150 |
Why?
|
| Female | 72 | 2023 | 391246 | 0.140 |
Why?
|
| China | 4 | 2011 | 2339 | 0.140 |
Why?
|
| Paranasal Sinuses | 2 | 1998 | 265 | 0.140 |
Why?
|
| Flavivirus | 1 | 2015 | 22 | 0.130 |
Why?
|
| Indium | 1 | 2015 | 46 | 0.130 |
Why?
|
| Gallium | 1 | 2015 | 27 | 0.130 |
Why?
|
| Encephalitis, Tick-Borne | 1 | 2015 | 37 | 0.130 |
Why?
|
| Encephalitis Viruses, Tick-Borne | 1 | 2015 | 43 | 0.130 |
Why?
|
| Cadherins | 1 | 2020 | 898 | 0.120 |
Why?
|
| Brain Neoplasms | 5 | 2023 | 8985 | 0.120 |
Why?
|
| Immunoconjugates | 1 | 2023 | 949 | 0.120 |
Why?
|
| Spinal Cord | 2 | 2021 | 1817 | 0.120 |
Why?
|
| Neuroendoscopy | 1 | 2016 | 98 | 0.120 |
Why?
|
| Adult | 53 | 2020 | 220007 | 0.120 |
Why?
|
| Intraoperative Care | 7 | 2001 | 768 | 0.120 |
Why?
|
| Silver | 1 | 2015 | 120 | 0.120 |
Why?
|
| Hypothermia, Induced | 1 | 2020 | 758 | 0.120 |
Why?
|
| Middle Aged | 53 | 2020 | 220359 | 0.120 |
Why?
|
| Endoscopy | 3 | 1998 | 1838 | 0.110 |
Why?
|
| Neuronavigation | 1 | 2015 | 164 | 0.110 |
Why?
|
| Vertebral Artery | 2 | 2010 | 185 | 0.110 |
Why?
|
| Genetic Variation | 5 | 2010 | 6552 | 0.110 |
Why?
|
| Age of Onset | 3 | 2005 | 3302 | 0.110 |
Why?
|
| Male | 57 | 2020 | 359718 | 0.100 |
Why?
|
| Research Design | 1 | 2008 | 6180 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2011 | 452 | 0.100 |
Why?
|
| Organometallic Compounds | 2 | 2015 | 662 | 0.100 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2020 | 1032 | 0.100 |
Why?
|
| Body Weight | 5 | 2003 | 4611 | 0.100 |
Why?
|
| Aged | 39 | 2020 | 169143 | 0.100 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2014 | 251 | 0.100 |
Why?
|
| Computer Simulation | 4 | 2008 | 6218 | 0.100 |
Why?
|
| Pituitary Neoplasms | 2 | 2016 | 1313 | 0.100 |
Why?
|
| Emergencies | 1 | 2018 | 1210 | 0.100 |
Why?
|
| Risk Factors | 16 | 2014 | 74333 | 0.100 |
Why?
|
| Aphasia | 1 | 2013 | 192 | 0.100 |
Why?
|
| Selenoprotein P | 1 | 2011 | 33 | 0.100 |
Why?
|
| Calcium, Dietary | 1 | 2014 | 531 | 0.100 |
Why?
|
| Malformations of Cortical Development | 1 | 2013 | 177 | 0.100 |
Why?
|
| Inverted Repeat Sequences | 1 | 2011 | 61 | 0.090 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2014 | 540 | 0.090 |
Why?
|
| Likelihood Functions | 3 | 2010 | 987 | 0.090 |
Why?
|
| Microglia | 1 | 2020 | 1350 | 0.090 |
Why?
|
| Personality Inventory | 2 | 2005 | 1018 | 0.090 |
Why?
|
| Chromosome Aberrations | 2 | 2009 | 1767 | 0.090 |
Why?
|
| Vestibular Neuronitis | 1 | 2010 | 15 | 0.090 |
Why?
|
| Receptors, Interleukin | 1 | 2011 | 243 | 0.090 |
Why?
|
| Darkness | 1 | 2010 | 158 | 0.090 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2010 | 160 | 0.090 |
Why?
|
| Receptors, Pheromone | 1 | 2009 | 3 | 0.090 |
Why?
|
| Methods | 1 | 2010 | 1074 | 0.090 |
Why?
|
| Glutathione Peroxidase | 1 | 2011 | 256 | 0.090 |
Why?
|
| Biodegradation, Environmental | 1 | 2010 | 218 | 0.090 |
Why?
|
| Body Height | 3 | 2014 | 1570 | 0.090 |
Why?
|
| Intracranial Embolism | 1 | 2011 | 192 | 0.090 |
Why?
|
| Candida | 1 | 1990 | 173 | 0.090 |
Why?
|
| Models, Statistical | 3 | 2010 | 5075 | 0.080 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2009 | 58 | 0.080 |
Why?
|
| Steroid Hydroxylases | 1 | 2009 | 96 | 0.080 |
Why?
|
| Antigens, CD | 1 | 2020 | 4000 | 0.080 |
Why?
|
| Neoplasms | 1 | 2018 | 22075 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2010 | 534 | 0.080 |
Why?
|
| Solubility | 1 | 2010 | 1088 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2011 | 23374 | 0.080 |
Why?
|
| Selenium | 1 | 2011 | 416 | 0.080 |
Why?
|
| Endoscopes | 3 | 1998 | 168 | 0.080 |
Why?
|
| Health Status Disparities | 1 | 2020 | 1829 | 0.080 |
Why?
|
| Penetrance | 1 | 2009 | 388 | 0.070 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2013 | 708 | 0.070 |
Why?
|
| Twin Studies as Topic | 1 | 2007 | 104 | 0.070 |
Why?
|
| Regression Analysis | 2 | 2010 | 6359 | 0.070 |
Why?
|
| Genetic Loci | 2 | 2014 | 2618 | 0.070 |
Why?
|
| Sister Chromatid Exchange | 1 | 2007 | 60 | 0.070 |
Why?
|
| Gene Frequency | 3 | 2014 | 3613 | 0.070 |
Why?
|
| Olivary Nucleus | 1 | 2008 | 128 | 0.070 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2008 | 318 | 0.070 |
Why?
|
| Principal Component Analysis | 1 | 2010 | 939 | 0.070 |
Why?
|
| Endocarditis | 1 | 2011 | 351 | 0.070 |
Why?
|
| Dinoprostone | 1 | 2010 | 598 | 0.070 |
Why?
|
| Genotype | 8 | 2014 | 12957 | 0.070 |
Why?
|
| Aged, 80 and over | 15 | 2020 | 58980 | 0.070 |
Why?
|
| Gene Amplification | 1 | 2011 | 1085 | 0.070 |
Why?
|
| Wnt Proteins | 1 | 2011 | 719 | 0.070 |
Why?
|
| Hormones | 1 | 2010 | 867 | 0.070 |
Why?
|
| Equipment Design | 4 | 2005 | 3520 | 0.070 |
Why?
|
| Body Image | 3 | 2005 | 635 | 0.070 |
Why?
|
| Glioma | 2 | 2015 | 3420 | 0.070 |
Why?
|
| Genes, BRCA1 | 1 | 2009 | 765 | 0.060 |
Why?
|
| Epidemiologic Methods | 1 | 2010 | 1343 | 0.060 |
Why?
|
| Adolescent | 18 | 2020 | 87809 | 0.060 |
Why?
|
| Pituitary Gland | 2 | 2016 | 637 | 0.060 |
Why?
|
| Alleles | 2 | 2014 | 6900 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2010 | 2502 | 0.060 |
Why?
|
| Lipoprotein Lipase | 1 | 2006 | 134 | 0.060 |
Why?
|
| DNA Copy Number Variations | 2 | 2011 | 2013 | 0.060 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2005 | 122 | 0.060 |
Why?
|
| Comparative Genomic Hybridization | 3 | 2011 | 473 | 0.060 |
Why?
|
| Isoproterenol | 2 | 2004 | 394 | 0.060 |
Why?
|
| Postmenopause | 1 | 2014 | 2509 | 0.060 |
Why?
|
| Hormone Replacement Therapy | 1 | 2010 | 755 | 0.060 |
Why?
|
| Genetics, Population | 1 | 2009 | 929 | 0.060 |
Why?
|
| Pregnancy | 3 | 2019 | 29746 | 0.060 |
Why?
|
| Electroencephalography | 1 | 2020 | 6189 | 0.060 |
Why?
|
| Body Composition | 2 | 2005 | 2419 | 0.060 |
Why?
|
| Oxidation-Reduction | 1 | 2010 | 2222 | 0.060 |
Why?
|
| Mammals | 1 | 2009 | 1131 | 0.060 |
Why?
|
| Genetic Markers | 1 | 2010 | 2609 | 0.060 |
Why?
|
| Kinetics | 2 | 2010 | 6377 | 0.050 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 1763 | 0.050 |
Why?
|
| Cultural Characteristics | 1 | 2005 | 253 | 0.050 |
Why?
|
| Astrocytoma | 1 | 2008 | 775 | 0.050 |
Why?
|
| Radiation Dosage | 1 | 2011 | 1957 | 0.050 |
Why?
|
| Cerebellar Neoplasms | 1 | 2008 | 586 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 1 | 1990 | 2693 | 0.050 |
Why?
|
| DNA, Neoplasm | 2 | 2005 | 1745 | 0.050 |
Why?
|
| Electrodes | 1 | 2005 | 614 | 0.050 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2004 | 345 | 0.050 |
Why?
|
| Meningeal Neoplasms | 1 | 2011 | 1249 | 0.050 |
Why?
|
| Maxillary Sinus Neoplasms | 1 | 2002 | 39 | 0.050 |
Why?
|
| Electrophysiology | 1 | 2005 | 1265 | 0.050 |
Why?
|
| Radiography | 3 | 2011 | 6965 | 0.050 |
Why?
|
| Brain | 9 | 2015 | 26951 | 0.050 |
Why?
|
| BRCA2 Protein | 1 | 2006 | 798 | 0.050 |
Why?
|
| Young Adult | 8 | 2020 | 58748 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2009 | 1885 | 0.050 |
Why?
|
| Appendicitis | 1 | 2007 | 674 | 0.050 |
Why?
|
| Prostatic Neoplasms | 4 | 2009 | 11345 | 0.050 |
Why?
|
| Telomere | 1 | 2007 | 934 | 0.050 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2009 | 1152 | 0.050 |
Why?
|
| Carcinoma, Lobular | 1 | 2004 | 489 | 0.040 |
Why?
|
| Prognosis | 7 | 2020 | 29661 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2010 | 3765 | 0.040 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2004 | 866 | 0.040 |
Why?
|
| Retrospective Studies | 9 | 2023 | 80345 | 0.040 |
Why?
|
| BRCA1 Protein | 1 | 2006 | 1147 | 0.040 |
Why?
|
| Bacteria | 1 | 1990 | 2199 | 0.040 |
Why?
|
| Recovery of Function | 2 | 2020 | 2985 | 0.040 |
Why?
|
| Chondrosarcoma | 1 | 2002 | 296 | 0.040 |
Why?
|
| Loss of Heterozygosity | 1 | 2002 | 659 | 0.040 |
Why?
|
| Paranasal Sinus Neoplasms | 2 | 1998 | 241 | 0.040 |
Why?
|
| Neurosurgical Procedures | 2 | 2008 | 2056 | 0.040 |
Why?
|
| SEER Program | 1 | 2004 | 1530 | 0.040 |
Why?
|
| Camptothecin | 1 | 2023 | 590 | 0.040 |
Why?
|
| Sinusitis | 2 | 1998 | 990 | 0.040 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2011 | 2496 | 0.040 |
Why?
|
| Tension-Type Headache | 1 | 2000 | 76 | 0.040 |
Why?
|
| Electronics, Medical | 1 | 1998 | 72 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2009 | 2505 | 0.040 |
Why?
|
| Barrett Esophagus | 1 | 2002 | 490 | 0.040 |
Why?
|
| Encephalomyelitis, Equine | 1 | 1997 | 13 | 0.040 |
Why?
|
| Arachnoid Cysts | 1 | 1998 | 61 | 0.040 |
Why?
|
| Encephalitis Virus, Eastern Equine | 1 | 1997 | 12 | 0.040 |
Why?
|
| Hospital Design and Construction | 1 | 1997 | 33 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2008 | 9278 | 0.040 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2004 | 1096 | 0.040 |
Why?
|
| Infrared Rays | 1 | 1998 | 246 | 0.040 |
Why?
|
| Anesthesia, General | 3 | 1998 | 1166 | 0.040 |
Why?
|
| Treatment Outcome | 5 | 2023 | 64981 | 0.030 |
Why?
|
| Optics and Photonics | 1 | 1998 | 305 | 0.030 |
Why?
|
| Biopsy | 3 | 2013 | 6771 | 0.030 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2020 | 352 | 0.030 |
Why?
|
| Pre-Eclampsia | 1 | 2006 | 1229 | 0.030 |
Why?
|
| Dexamethasone | 1 | 1983 | 1927 | 0.030 |
Why?
|
| Fear | 1 | 2005 | 1462 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2010 | 1431 | 0.030 |
Why?
|
| New Hampshire | 1 | 2015 | 173 | 0.030 |
Why?
|
| Ixodes | 1 | 2015 | 40 | 0.030 |
Why?
|
| Muscle, Smooth | 2 | 1990 | 924 | 0.030 |
Why?
|
| Vitamin D | 1 | 2009 | 3291 | 0.030 |
Why?
|
| Lumbar Vertebrae | 2 | 1998 | 1868 | 0.030 |
Why?
|
| Follow-Up Studies | 5 | 2005 | 39262 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 6 | 1999 | 20509 | 0.030 |
Why?
|
| Pituitary Diseases | 1 | 2016 | 135 | 0.030 |
Why?
|
| Precancerous Conditions | 1 | 2002 | 977 | 0.030 |
Why?
|
| Tuberculosis, Spinal | 2 | 1990 | 16 | 0.030 |
Why?
|
| Statistics, Nonparametric | 3 | 2009 | 2852 | 0.030 |
Why?
|
| Acyclovir | 1 | 2015 | 269 | 0.030 |
Why?
|
| Muscle Contraction | 2 | 1990 | 1201 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 1998 | 682 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2005 | 4089 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2006 | 7593 | 0.030 |
Why?
|
| Craniotomy | 1 | 1999 | 741 | 0.030 |
Why?
|
| Prospective Studies | 4 | 2023 | 54306 | 0.030 |
Why?
|
| Electron Transport | 1 | 2015 | 206 | 0.030 |
Why?
|
| Gastric Bypass | 1 | 2003 | 826 | 0.030 |
Why?
|
| Odds Ratio | 3 | 2011 | 9716 | 0.030 |
Why?
|
| Posture | 1 | 1998 | 953 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2023 | 41337 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 6316 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2003 | 2029 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 2 | 1998 | 2882 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2014 | 194 | 0.030 |
Why?
|
| Meningitis, Bacterial | 1 | 2015 | 221 | 0.030 |
Why?
|
| Nose Neoplasms | 3 | 2002 | 249 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 1999 | 8950 | 0.030 |
Why?
|
| Laryngoscopy | 1 | 1999 | 706 | 0.030 |
Why?
|
| Airway Obstruction | 1 | 1998 | 662 | 0.030 |
Why?
|
| Diet | 4 | 2014 | 8010 | 0.030 |
Why?
|
| Cluster Analysis | 2 | 2011 | 2698 | 0.030 |
Why?
|
| Starvation | 1 | 1993 | 140 | 0.030 |
Why?
|
| Women's Health | 2 | 2014 | 2056 | 0.030 |
Why?
|
| Nasal Polyps | 1 | 1998 | 395 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2014 | 385 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2014 | 419 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2003 | 6015 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 1998 | 1630 | 0.030 |
Why?
|
| Cyclosporine | 1 | 1995 | 777 | 0.030 |
Why?
|
| Neurologic Examination | 2 | 2015 | 916 | 0.030 |
Why?
|
| Animals | 8 | 2020 | 167960 | 0.030 |
Why?
|
| Phenotype | 3 | 2010 | 16548 | 0.030 |
Why?
|
| Carotid Artery, Internal | 1 | 1995 | 438 | 0.030 |
Why?
|
| Cerebral Angiography | 2 | 1996 | 1274 | 0.030 |
Why?
|
| Survival Rate | 3 | 2015 | 12810 | 0.030 |
Why?
|
| Receptor, erbB-2 | 1 | 2023 | 2554 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 8512 | 0.030 |
Why?
|
| Kyphosis | 2 | 1990 | 237 | 0.020 |
Why?
|
| Obesity, Morbid | 1 | 2003 | 1287 | 0.020 |
Why?
|
| Esophageal Neoplasms | 1 | 2002 | 1648 | 0.020 |
Why?
|
| Diagnosis, Differential | 3 | 2013 | 12968 | 0.020 |
Why?
|
| Weight Loss | 1 | 2003 | 2684 | 0.020 |
Why?
|
| Craniocerebral Trauma | 1 | 1996 | 491 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2003 | 12914 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 1998 | 1501 | 0.020 |
Why?
|
| United States | 6 | 2015 | 72448 | 0.020 |
Why?
|
| Logistic Models | 3 | 2011 | 13312 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2002 | 4024 | 0.020 |
Why?
|
| Caloric Tests | 1 | 2010 | 10 | 0.020 |
Why?
|
| Sex Factors | 1 | 2005 | 10546 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2015 | 1895 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 1983 | 3726 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1999 | 2197 | 0.020 |
Why?
|
| Myosin Subfragments | 1 | 1989 | 20 | 0.020 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 1989 | 41 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2011 | 410 | 0.020 |
Why?
|
| Bulimia | 1 | 1992 | 399 | 0.020 |
Why?
|
| Vomeronasal Organ | 1 | 2009 | 20 | 0.020 |
Why?
|
| Wolves | 1 | 2009 | 10 | 0.020 |
Why?
|
| Genes, myc | 1 | 2011 | 395 | 0.020 |
Why?
|
| Gadolinium DTPA | 3 | 1998 | 823 | 0.020 |
Why?
|
| Central Nervous System | 1 | 1997 | 1334 | 0.020 |
Why?
|
| Multiple Sclerosis | 2 | 1995 | 3204 | 0.020 |
Why?
|
| Genetic Speciation | 1 | 2009 | 38 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2011 | 430 | 0.020 |
Why?
|
| Culture | 1 | 1993 | 622 | 0.020 |
Why?
|
| Seasons | 1 | 2015 | 1522 | 0.020 |
Why?
|
| Benchmarking | 1 | 2016 | 1044 | 0.020 |
Why?
|
| Prevalence | 4 | 2015 | 15686 | 0.020 |
Why?
|
| Carbachol | 1 | 1989 | 223 | 0.020 |
Why?
|
| Ear Canal | 1 | 2010 | 146 | 0.020 |
Why?
|
| Chronic Disease | 3 | 2000 | 9288 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2004 | 2557 | 0.020 |
Why?
|
| Bacterial Adhesion | 1 | 1990 | 306 | 0.020 |
Why?
|
| Age Factors | 3 | 2011 | 18413 | 0.020 |
Why?
|
| Headache | 1 | 1997 | 1249 | 0.020 |
Why?
|
| Stroke | 1 | 2011 | 9952 | 0.020 |
Why?
|
| Corpus Callosum | 1 | 2013 | 749 | 0.020 |
Why?
|
| Population Surveillance | 1 | 1999 | 2608 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2009 | 314 | 0.020 |
Why?
|
| Time Factors | 1 | 2010 | 40139 | 0.020 |
Why?
|
| Progestins | 1 | 2010 | 302 | 0.020 |
Why?
|
| Carotid Artery Diseases | 1 | 1995 | 881 | 0.020 |
Why?
|
| Sacrum | 1 | 1990 | 277 | 0.020 |
Why?
|
| Myosins | 1 | 1990 | 405 | 0.020 |
Why?
|
| Vestibule, Labyrinth | 1 | 2010 | 232 | 0.020 |
Why?
|
| Mouth | 1 | 1990 | 380 | 0.020 |
Why?
|
| Methicillin | 1 | 1988 | 62 | 0.020 |
Why?
|
| Life Style | 2 | 2010 | 3898 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 11902 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2010 | 350 | 0.020 |
Why?
|
| Acute Disease | 1 | 1998 | 7268 | 0.020 |
Why?
|
| Hypesthesia | 1 | 2008 | 107 | 0.020 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 17624 | 0.020 |
Why?
|
| Risk | 2 | 2010 | 9632 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2009 | 470 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 1994 | 1826 | 0.020 |
Why?
|
| Migraine Disorders | 1 | 2000 | 1693 | 0.020 |
Why?
|
| Receptors, Calcitriol | 1 | 2009 | 359 | 0.020 |
Why?
|
| Gene Expression Profiling | 3 | 2009 | 9406 | 0.020 |
Why?
|
| Postoperative Complications | 4 | 2016 | 15679 | 0.020 |
Why?
|
| Multigene Family | 1 | 2009 | 1077 | 0.020 |
Why?
|
| Incidence | 1 | 2005 | 21391 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2011 | 1376 | 0.020 |
Why?
|
| Ear, Inner | 1 | 2010 | 424 | 0.020 |
Why?
|
| Fish Oils | 1 | 2010 | 482 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2008 | 555 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2014 | 1842 | 0.020 |
Why?
|
| Models, Biological | 3 | 2008 | 9468 | 0.020 |
Why?
|
| Mutation | 2 | 2009 | 29957 | 0.020 |
Why?
|
| beta Catenin | 1 | 2011 | 1043 | 0.020 |
Why?
|
| Ataxia | 1 | 2008 | 305 | 0.020 |
Why?
|
| History, 20th Century | 1 | 1993 | 2773 | 0.020 |
Why?
|
| Neutropenia | 1 | 1990 | 884 | 0.020 |
Why?
|
| Monitoring, Intraoperative | 2 | 2005 | 942 | 0.020 |
Why?
|
| Species Specificity | 1 | 2009 | 2418 | 0.020 |
Why?
|
| Research | 1 | 1993 | 1974 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2007 | 442 | 0.020 |
Why?
|
| Muscles | 1 | 1990 | 1581 | 0.020 |
Why?
|
| Dogs | 1 | 2009 | 3841 | 0.010 |
Why?
|
| Intracranial Aneurysm | 1 | 1994 | 1276 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2015 | 3142 | 0.010 |
Why?
|
| Disease Progression | 2 | 2013 | 13505 | 0.010 |
Why?
|
| Estrogens | 1 | 2010 | 1520 | 0.010 |
Why?
|
| Radioisotope Dilution Technique | 1 | 2003 | 71 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2010 | 2253 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2011 | 2943 | 0.010 |
Why?
|
| Rabbits | 1 | 2009 | 4773 | 0.010 |
Why?
|
| Glioblastoma | 1 | 1998 | 3482 | 0.010 |
Why?
|
| Neoplasm Staging | 2 | 2010 | 11152 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2011 | 16932 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2015 | 3061 | 0.010 |
Why?
|
| Densitometry | 1 | 2003 | 151 | 0.010 |
Why?
|
| Dietary Fats | 1 | 2011 | 1992 | 0.010 |
Why?
|
| Flow Cytometry | 2 | 2004 | 5869 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2009 | 1738 | 0.010 |
Why?
|
| Colonoscopy | 1 | 2011 | 1387 | 0.010 |
Why?
|
| Massachusetts | 1 | 2015 | 8803 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 4046 | 0.010 |
Why?
|
| Menopause | 1 | 2010 | 1640 | 0.010 |
Why?
|
| Nasal Bone | 1 | 2002 | 57 | 0.010 |
Why?
|
| Hypertriglyceridemia | 1 | 2006 | 316 | 0.010 |
Why?
|
| Phylogeny | 1 | 2009 | 2775 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 3465 | 0.010 |
Why?
|
| Child | 7 | 2002 | 79799 | 0.010 |
Why?
|
| Haplotypes | 1 | 2008 | 2764 | 0.010 |
Why?
|
| Hospitals, Psychiatric | 1 | 1983 | 320 | 0.010 |
Why?
|
| Mice | 3 | 2020 | 81209 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2011 | 4122 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2008 | 3094 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 22020 | 0.010 |
Why?
|
| Ischemia | 1 | 2010 | 1893 | 0.010 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2009 | 1596 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 2716 | 0.010 |
Why?
|
| Metaplasia | 1 | 2002 | 320 | 0.010 |
Why?
|
| Freezing | 1 | 2002 | 306 | 0.010 |
Why?
|
| Tandem Repeat Sequences | 1 | 2002 | 181 | 0.010 |
Why?
|
| Developing Countries | 1 | 1993 | 2868 | 0.010 |
Why?
|
| Tissue Fixation | 1 | 2002 | 241 | 0.010 |
Why?
|
| Sphenoid Sinus | 1 | 2001 | 99 | 0.010 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2010 | 1387 | 0.010 |
Why?
|
| Contrast Media | 3 | 1998 | 5305 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 4626 | 0.010 |
Why?
|
| Prostatic Hyperplasia | 1 | 2004 | 530 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 2282 | 0.010 |
Why?
|
| Mammography | 1 | 2010 | 2427 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2005 | 2932 | 0.010 |
Why?
|
| San Francisco | 1 | 1999 | 162 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2007 | 6130 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2002 | 748 | 0.010 |
Why?
|
| Spinal Canal | 1 | 1998 | 41 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 2002 | 599 | 0.010 |
Why?
|
| Disease Notification | 1 | 1999 | 97 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4571 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 1988 | 1407 | 0.010 |
Why?
|
| Ethmoid Sinus | 1 | 1998 | 57 | 0.010 |
Why?
|
| Taiwan | 1 | 2000 | 505 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 4716 | 0.010 |
Why?
|
| Blood Proteins | 1 | 2004 | 1173 | 0.010 |
Why?
|
| Electric Impedance | 1 | 2003 | 755 | 0.010 |
Why?
|
| Petrous Bone | 1 | 1998 | 84 | 0.010 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 1998 | 141 | 0.010 |
Why?
|
| Aging | 1 | 1997 | 8652 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 1999 | 516 | 0.010 |
Why?
|
| Pharyngeal Neoplasms | 1 | 1998 | 113 | 0.010 |
Why?
|
| Radiotherapy, High-Energy | 1 | 1998 | 228 | 0.010 |
Why?
|
| Skull Neoplasms | 1 | 1998 | 173 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2008 | 4902 | 0.010 |
Why?
|
| Feasibility Studies | 2 | 1998 | 5201 | 0.010 |
Why?
|
| Adenoma, Pleomorphic | 1 | 1998 | 75 | 0.010 |
Why?
|
| Online Systems | 1 | 1998 | 181 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2013 | 6465 | 0.010 |
Why?
|
| Maxillary Sinus | 1 | 1998 | 180 | 0.010 |
Why?
|
| Hospital Departments | 1 | 1997 | 136 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1999 | 1628 | 0.010 |
Why?
|
| Tongue Neoplasms | 1 | 1998 | 183 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2004 | 2192 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2010 | 24102 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2004 | 2210 | 0.010 |
Why?
|
| Parotid Neoplasms | 1 | 1998 | 157 | 0.010 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 1996 | 59 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2010 | 12427 | 0.010 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 1998 | 286 | 0.010 |
Why?
|
| Laryngeal Diseases | 1 | 1999 | 244 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1998 | 1385 | 0.010 |
Why?
|
| Child, Preschool | 6 | 1999 | 42056 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1983 | 1803 | 0.010 |
Why?
|
| Pentetic Acid | 1 | 1995 | 209 | 0.010 |
Why?
|
| Hypertension | 1 | 1995 | 8595 | 0.010 |
Why?
|
| Skull Base Neoplasms | 1 | 1998 | 269 | 0.010 |
Why?
|
| Hematoma, Subdural | 1 | 1996 | 126 | 0.010 |
Why?
|
| Meglumine | 1 | 1995 | 145 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 10442 | 0.010 |
Why?
|
| Office Visits | 1 | 1999 | 597 | 0.010 |
Why?
|
| Feedback | 1 | 1998 | 791 | 0.010 |
Why?
|
| Neuroma, Acoustic | 1 | 1998 | 459 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2000 | 2294 | 0.010 |
Why?
|
| Skull Fractures | 1 | 1996 | 202 | 0.010 |
Why?
|
| Traction | 1 | 1974 | 106 | 0.010 |
Why?
|
| Anemia, Hemolytic | 1 | 1995 | 163 | 0.010 |
Why?
|
| Registries | 1 | 2010 | 8458 | 0.010 |
Why?
|
| Laryngeal Neoplasms | 1 | 1998 | 514 | 0.010 |
Why?
|
| Larynx | 1 | 1999 | 492 | 0.010 |
Why?
|
| Neurons | 1 | 2013 | 9424 | 0.010 |
Why?
|
| Echo-Planar Imaging | 1 | 1998 | 657 | 0.010 |
Why?
|
| Temporal Bone | 1 | 1998 | 683 | 0.010 |
Why?
|
| Neck | 1 | 1998 | 731 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2004 | 20080 | 0.010 |
Why?
|
| Conscious Sedation | 1 | 1998 | 529 | 0.010 |
Why?
|
| Video Recording | 1 | 1998 | 955 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2010 | 11481 | 0.010 |
Why?
|
| Ambulatory Care Facilities | 1 | 1999 | 926 | 0.010 |
Why?
|
| Spinal Fusion | 2 | 1990 | 1281 | 0.010 |
Why?
|
| Analgesics | 1 | 2000 | 1065 | 0.010 |
Why?
|
| Infant | 4 | 1999 | 36053 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1995 | 674 | 0.010 |
Why?
|
| Hyperphagia | 1 | 1992 | 138 | 0.010 |
Why?
|
| Personality Development | 1 | 1992 | 244 | 0.010 |
Why?
|
| Cerebral Arteries | 1 | 1994 | 493 | 0.010 |
Why?
|
| Cadaver | 1 | 1996 | 1345 | 0.010 |
Why?
|
| Spinal Neoplasms | 1 | 1998 | 716 | 0.010 |
Why?
|
| Reference Values | 1 | 1998 | 4925 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 11070 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2003 | 3300 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2002 | 3022 | 0.010 |
Why?
|
| Liver | 1 | 2006 | 7510 | 0.010 |
Why?
|
| Head | 1 | 1996 | 922 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1989 | 283 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2002 | 3663 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1989 | 262 | 0.010 |
Why?
|
| Artifacts | 1 | 1998 | 1898 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1995 | 2025 | 0.010 |
Why?
|
| Osteotomy | 1 | 1974 | 836 | 0.010 |
Why?
|
| Radiosurgery | 1 | 1998 | 1343 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1997 | 6238 | 0.000 |
Why?
|
| Phosphopeptides | 1 | 1989 | 241 | 0.000 |
Why?
|
| Phosphorylation | 2 | 1990 | 8311 | 0.000 |
Why?
|
| Debridement | 1 | 1990 | 492 | 0.000 |
Why?
|
| Thrombocytopenia | 1 | 1995 | 1174 | 0.000 |
Why?
|
| Sarcoma | 1 | 1998 | 1786 | 0.000 |
Why?
|
| Social Environment | 1 | 1992 | 1022 | 0.000 |
Why?
|
| Image Enhancement | 1 | 1998 | 2881 | 0.000 |
Why?
|
| Gender Identity | 1 | 1992 | 698 | 0.000 |
Why?
|
| Back Pain | 1 | 1990 | 543 | 0.000 |
Why?
|
| Anesthesiology | 1 | 1996 | 1116 | 0.000 |
Why?
|
| Hospitals | 1 | 1999 | 3928 | 0.000 |
Why?
|
| Anesthesia | 1 | 1996 | 1584 | 0.000 |
Why?
|
| Drug Resistance, Microbial | 1 | 1988 | 856 | 0.000 |
Why?
|
| Infant, Newborn | 2 | 1999 | 26179 | 0.000 |
Why?
|
| Brain Injuries | 1 | 1996 | 2044 | 0.000 |
Why?
|
| Cattle | 1 | 1989 | 3847 | 0.000 |
Why?
|
| Trachea | 1 | 1989 | 1082 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 1998 | 14661 | 0.000 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1998 | 3218 | 0.000 |
Why?
|
| Depression | 1 | 2000 | 8045 | 0.000 |
Why?
|
| Staphylococcus aureus | 1 | 1988 | 1462 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1990 | 13451 | 0.000 |
Why?
|
| Aminosalicylic Acids | 1 | 1974 | 37 | 0.000 |
Why?
|
| Streptomycin | 1 | 1974 | 70 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1989 | 18955 | 0.000 |
Why?
|
| Isoniazid | 1 | 1974 | 283 | 0.000 |
Why?
|
| Respiratory Function Tests | 1 | 1974 | 1683 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1988 | 7408 | 0.000 |
Why?
|